Seeking Alpha

HYDRO

HYDRO
Send Message
View as an RSS Feed
View HYDRO's Comments BY TICKER:
Latest  |  Highest rated
  • Getting The Dope On These OTC Cannabis Stocks [View article]
    Well said! This is the tip of the iceberg Still have about 30 other companies to cover in this new industry...MCIG has been around and successful in the smokeless cig market...They are structured and have a nation wide distribution chain already in place.. I have to say one of the better write ups on this industry
    Feb 8 03:12 PM | Likes Like |Link to Comment
  • Medical Marijuana, GW Pharma rally amid Colorado euphoria; peers tumble [View news story]
    That is true a ETF is on it's way but these companies are small enough to buy a block and hope for the best..This Industry is going to grow any way you look at it...
    Jan 13 08:28 AM | 1 Like Like |Link to Comment
  • Medical Marijuana, GW Pharma rally amid Colorado euphoria; peers tumble [View news story]
    do not deal with a bank..open a account with a TRUE broker...TD AMERTRADE....CHARLES SCHWAB..JUST GOOGLE BROKERS AND YOU CAN PICK WHO YOU WANT
    Jan 12 10:40 AM | Likes Like |Link to Comment
  • Medical Marijuana, GW Pharma rally amid Colorado euphoria; peers tumble [View news story]
    There are going to be winners & losers but who is fooling who here. .This is the start of a whole new industry. Big tobacco and Alcohol are scared
    Jan 10 04:12 PM | 1 Like Like |Link to Comment
  • Noodles & Co beats by $0.01, beats on revenues [View news story]
    DID IT FALL ASLEEP...
    Aug 8 04:26 PM | Likes Like |Link to Comment
  • "Apple's (AAPL) glory days are now behind it," said FBN's Shebly Seyrafi on Thursday morning with the stock at $450. On Sept. 13 - the day after the iPhone 5 launch and the shares at $680 - Seyrafi reiterated a Buy rating and boosted his price target to $1,000. (FBN now maintains an Outperform on Apple with a lowered target of $650.) [View news story]
    Crapple is Kaput..Cook and his crew are greedy. Cook knew they missed their numbers and should of did a buy back and the biggest dividend of all companies!..Buy put's and short it..This Market is flying but will land soon enough..
    Jan 26 08:06 PM | Likes Like |Link to Comment
  • Sarepta Therapeutics (SRPT -7.6%) reversed an early gain to continue its descent lower today, despite issuing a positive update from Phase IIb testing of its eteplirsen drug treatment for Duchenne muscular dystrophy. The company says data continues to show a statistically significant clinical benefit for patients after 62 weeks. Unfortunately, the stock has been in a steady decline since the company gave its presentation at the Deutsche Bank 2012 dbAccess BioFEST Conference in Boston on Tuesday. [View news story]
    Does anyone have a idea why SRPT going to sell shares? Is this good.bad or ugly for the longs in this position?
    Dec 12 05:56 PM | Likes Like |Link to Comment
  • Sarepta Therapeutics (SRPT -7.6%) reversed an early gain to continue its descent lower today, despite issuing a positive update from Phase IIb testing of its eteplirsen drug treatment for Duchenne muscular dystrophy. The company says data continues to show a statistically significant clinical benefit for patients after 62 weeks. Unfortunately, the stock has been in a steady decline since the company gave its presentation at the Deutsche Bank 2012 dbAccess BioFEST Conference in Boston on Tuesday. [View news story]
    We are all here to make money but I do hope for the sake of these kids this drug works. You can almost feel guilty if you short this company.I hope they find a cure at the end of it all..
    Dec 8 10:17 AM | Likes Like |Link to Comment
  • Sarepta Therapeutics (SRPT -7.6%) reversed an early gain to continue its descent lower today, despite issuing a positive update from Phase IIb testing of its eteplirsen drug treatment for Duchenne muscular dystrophy. The company says data continues to show a statistically significant clinical benefit for patients after 62 weeks. Unfortunately, the stock has been in a steady decline since the company gave its presentation at the Deutsche Bank 2012 dbAccess BioFEST Conference in Boston on Tuesday. [View news story]
    Does anyone know why this stock in tanking?
    Dec 7 05:00 PM | Likes Like |Link to Comment
  • Fossil (FOSL): Q2 EPS of $0.92 beats by $0.14. Revenue of $636M (+14.3% Y/Y) beats by $1.5M. (PR[View news story]
    Does anyone know how come FOSL did not release a time for there earnings call?
    Aug 7 09:18 AM | Likes Like |Link to Comment
  • Should Facebook Make Users Pay? [View article]
    A FEE??? IS THAT MINUS THE THE LOSS ON MY I.P.O. SHARES???
    Jul 29 11:05 PM | Likes Like |Link to Comment
  • Cramer's Mad Money - Arena's Teachable Moment (7/11/12) [View article]
    just do the opposite of what jim says and you will make$$$$$..
    Jul 22 10:27 AM | Likes Like |Link to Comment
  • Vivus (VVUS) shares are predictably chomping at the bit premarket, surging 13.3% after the FDA yesterday approved its weight-loss drug Qnexa/Qsymia. Shares had fallen sharply prior to the announcement. Also this morning, rivals Arena (ARNA) -5.9% and Orexigen Therapeutics (OREX) +3.2%.  [View news story]
    ARNA is held mostly by the common person.VVUS is held mostly by the institutions..I still think Arna will prevail and this company will double.Wall street games again...
    Jul 18 09:05 AM | Likes Like |Link to Comment
  • Vivus (VVUS +0.2%) shares reverse course after suffering heavy losses earlier and hover around zero after USA Today reports that the FDA has approved its Qnexa/Qysemia diet drug. However, no other news organizations appear to have reported the story, and it's not on the FDA website. Update: the linked-story in this MC seems to have been taken down. Vivus shares -0.6%.  [View news story]
    USAToday and FOX get there news from same source...
    Jul 17 01:45 PM | 1 Like Like |Link to Comment
  • Cramer's Mad Money - Arena's Teachable Moment (7/11/12) [View article]
    Cramer is a hypocrite.It is sad that he has a audience that follows him..WAKE UP PEOPLE....ARNA is a buy on the dips,the drug is in and there is no speculation in that...
    Jul 12 11:05 AM | 2 Likes Like |Link to Comment
COMMENTS STATS
27 Comments
12 Likes